Strategic, philanthropic and financial investors are among the early subscribers to Cross-Border Impact Ventures’ debut fund, which is in the market seeking $100 million. The Women’s and Children’s Health Technology Fund will focus primarily on medical device, diagnostic and digital health companies based in North America, Europe and Israel, the firm said last week. Its secondary focus will be on “commercial stage companies in emerging markets with global technology transfer potential”.
The fund has thus fair raised $30 million towards its target from investors including: The Children’s Investment Fund Foundation; Sida (The Swedish International Development Cooperation Agency); Rally Total Impact Fund; RockCreek; Grand Challenges Canada; and Global Health Investment Coorporation. A strategic investor from the healthcare sector – unnamed by the firm – is also among the investors.
Other fund notes, according to the firm:
- It will use a gender lens to invest.
- It has a stated target of 500,000 lives saved and “improvements in the lives of 10 million underserved women and children in emerging markets”.
- It is working towards EU SFDR Article 9 compliance.